Vimarsana
Biggest News Aggregation in the World

Page 20 - Dave Fredrickson News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Dave Fredrickson. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Dave Fredrickson Today - Breaking & Trending Today

Accelerated Approval for Enhertu, HER2-Mutant Metastatic NSCLC - Vimarsana News

Accelerated Approval for Enhertu, HER2-Mutant Metastatic NSCLC

The FDA has approved Enhertu (fam-trastuzumab deruxtecan-nxki) for previously treated adults with HER2-mutated unresectable or metastatic NSCLC.

Source: empr.com
AstraZeneca's Enhertu approved in the US for HER2-low metastatic breast cancer - Vimarsana News

AstraZeneca's Enhertu approved in the US for HER2-low metastatic breast cancer

AstraZeneca's Enhertu approved in the US for HER2-low metastatic breast cancer

AstraZeneca's Lynparza approved in EU for early breast cancer - DirectorsTalk Interviews - Vimarsana News

AstraZeneca's Lynparza approved in EU for early breast cancer - DirectorsTalk Interviews

AstraZeneca's Lynparza approved in EU for early breast cancer

AstraZeneca's Enhertu approved in the EU for HER2-positive mBC - DirectorsTalk Interviews - Vimarsana News

AstraZeneca's Enhertu approved in the EU for HER2-positive mBC - DirectorsTalk Interviews

AstraZeneca's Enhertu approved in the EU for HER2-positive mBC

Cancer treatments may benefit from lessons of pandemic set-backs - Vimarsana News

Cancer treatments may benefit from lessons of pandemic set-backs

Cancer treatments may benefit from lessons of pandemic set-backs